Use of Laser When the Balloon Cannot Cross

Slides:



Advertisements
Similar presentations
INTERVENTIONAL CARDIOLOGY AN OVERVIEW
Advertisements

Call for CASES Motaz AbuSamra Krzysztof Milewski CCU, Upper-Silesian Center of Cardiology, Silesian Medical School, Katowice, Poland Head of Department:
Introduction Recent guidelines considered PCI to be a potential alternative to CABG for ULMCA stenosis, based on several large registries and randomized.
How to deal with thrombus in ACS "Zap it" - Laser for Thrombus Suneel Talwar Dorset Heart Centre Royal Bournemouth Hospital.
AVE Micro Stent KFSH & RC Experience with 6 months Angiographic Follow Up Layth A. Mimish, M. Bakhshi, F. Al-Nozha, A. Kinsara, O. Amoudi, J. Buraiki,
Complications of HSRA Layth A. Mimish Consultant Cardiologist Cardiovascular Consultants Group Jeddah, Saudi Arabia.
29th ANNUAL SCIENTIFIC SESSIONS – SCA&I
Call for CASES Staged PCI in a patient with multivessel coronary disease disqualified from CABG. Pawel Buszman, MD, FESC, FSCAI Marcin Debinski, MD Krzysztof.
Call for CASES Leszek D. Stachaczyk, MD Pawel Buszman, MD, FESC, FSCAI American Heart of Poland, Ustroñ, Poland & CCU, Upper-Silesian Center of Cardiology,
Chaim Lotan MD, Yaron Almagor MD, Karel Kuiper MD, M.J. Suttorp MD, William Wijns MD The SICTO Study CYPHER TM Sirolimus-eluting stent in Chronic Total.
5F in 6F (7F) technique in DES era (Parent-child catheter technique)
Unstable angina and arterial hypertension Leszek Kinasz, MD American Heart of Poland Ustron, Poland.
One patient, two years, three choices, four PCI ZHAO Peng Cardiology , the Affiliated Hospital of Medical College of CPAPF, Tianjin, China.
TRANSRADIAL ROTABLATION OF A CASE OF CTO Dr. Christian Pristipino Coronary Intervention Unit San Filippo Neri Hospital Rome, Italy.
Featuring CTO Complex-PCI by Trans-radial Approach CTO Case review 5 French TRI CTO of right coronary artery -5 F Launcher guiding Catheter (right Judkins.
Retrograde approach for the Recanalizaiton of Coronary CTO: Preliminary Experience of Single Centre Lei Ge, Juying Qian, Xuebo Liu, Qin Qing, Junbo Ge.
Fu Wai Hospital Jie Qian
ROTAXUS A Prospective, Randomized Trial of High-Speed Rotational Atherectomy Prior to Paclitaxel-Eluting Stent Implantation in Complex Calcified Coronary.
The First Affiliated Hospital of Harbin Medical University
Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki.
The SAFER Trial Evaluation of the Clinical Safety and Efficacy of the PercuSurge GuardWire in Saphenous Vein Graft Intervention As presented at TCT 2000.
Ms. Leonardo Roever Coronary Stents. Coronary Artery Disease Leading cause of death in United States for men and women Caused by buildup of plaque in.
The Endocross Enabler-P: First in-Human Results
Adel Gamal, MD and Mohamed Saber, Msc
Disclosures Runlin Gao has received a research grant
Cutting Edge Case Presentation #1
G. Capretti, M. Carlino, A. Colombo, L. Azzalini
Takashi Ashikaga,MD,PhD
Successful transdradial removal of a dislodged coronary stent
Nightmares in the Cath Lab
Transradial Intervention: Complex Case Review Yes, They Can Be Done!
Runlin Gao, M.D. On behalf of ABSORB China Investigators
Interesting Case Presentation
European Registry Update
Advanced CTO Techniques:
Ben-Dor Itsik, MD Lowell Satler, MD Ron Waksman,MD Augusto Pichard, MD
Guideliner related stent stripping
Clinical Presentation
The Radial Approach for CTO PCI Utility in the Retrograde and the Antegrade Approaches Shigeru Saito, MD, FACC, FSCAI, FJCC Shonan Kamakura General Hospital.
Washington Hospital Center, Division of Cardiology
CRT 2017 Interventional Challenging Case Anterior ST- Elevation Myocardial Infarction Resulting From Acute Occlusion of Left Internal Mammary Artery Graft.
CRT Washington, D.C. February 23, 2010 Tim A. Fischell, M.D. FACC
Meruzhan Saghatelyan, MD, Interventional cardiologist
Procedural factors associated with PCI-related ischemic stroke
Use of Laser When the Balloon Cannot Cross
David J. Cohen, M.D., M.Sc. Director of Cardiovascular Research
The use of Laser for the treatment of coronary artery disease
Intra-Aortic Balloon Pump For Complex Calcified Left-Main Bifurcation Lesion Supawat Ratanapo, MD Medical College of Georgia, Augusta University.
How to do endovascular mechanical thrombaspiration
Excimer Laser Atherectomy for the Treatment of Infra-inguinal Peripheral Arterial Disease Bryan P Yan MD, Thomas J Kiernan MD, Vishal Gupta MD,
BVS Expand: First Results of Wide Clinical Applications
PCI in patients with cardiogenic shock associated with acute occlusion of the left main coronary artery.
Subintimal Tracking and Reentry for CTO STAR Method
Stent Thrombosis Rates in Contemporary Clinical Practice: Insight from a Large Australian Multi-centre Registry BP Yan*, TJ Kiernan, SJ Duffy, DJ Clark,
William A. Gray MD Director of Endovascular Services
Interesting Case Review
Essesntials for CTO Recanalization
FINAL FIVE-YEAR CLINICAL OUTCOMES OF THE NOBORI2 TRIAL
Incidence And Management Of Restenosis After Treatment Of Unprotected Left Main Disease With Drug-Eluting Stents: 70 Restenotic Cases From A Cohort Of.
Giuseppe Biondi Zoccai, MD
Hellenic PCI Registry Organization - Structure - Directions - Initial Recordings Georgios I. Papaioannou, MD, MPH, FACC,
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of.
12-month clinical and 13-month angiographic outcomes from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs. metallic drug-eluting.
Impact of Diabetes Mellitus on Long-term Outcomes in the
Maintenance of Long-Term Clinical Benefit with
ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions J. Mehilli, MD Deutsches Herzzentrum Technische.
ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions J. Mehilli, MD Deutsches Herzzentrum Technische.
Ahmed A. Khattab, MD For the German Cypher Registry Investigators
Atlantic Cardiovascular Patient Outcomes Research Team
Nicolas Mouawad, MD, Chief and Medical Director, Vascular and Endovascular Surgery, McLaren Bay Region A Tale of two lesions.
Presentation transcript:

Use of Laser When the Balloon Cannot Cross Cases and chronic total occlusion Itsik Ben-Dor, MD, Lowell Satler, MD, Augusto Pichard ,MD, Ron Waksman, MD Washington Hospital Center

I have no real or apparent conflicts of interest to report. Itsik Ben-Dor, MD I have no real or apparent conflicts of interest to report.

What it is Excimer Laser Coronary Atherectomy (ELCA)? Light Amplification Stimulated Emission Radiation

Catheter Overview 0.9mm RX and OTW (Concentric) 1.4mm RX (Concentric) 1.7mm RX (Eccentric & concentric) 2mm RX (Eccentric & concentric) Proximal Coupler Distal Tip

Excimer Laser Is a form of ultraviolet light. A cold laser which does not burn or cut. Vaporize tissue by breaking bonds between molecules.

Excimer Laser Coronary Atherectomy (ELCA) Ultraviolet energy photoablates arterial blockages into particles most of which are smaller than a red blood cell and are absorbed into the blood stream without embolizing distal capillaries The energy pulses create a forward acting vapor bubble that can weaken the very fibrotic proximal cap, vaporization of thrombi, ablation of underlying atherosclerotic plaque. The Size of the Vapor Bubble is dependent upon the fluency delivered  Photochemical  Photothermal  Photomechanical Dissolving molecular bonds Produces photo-thermal energy Creating kinetic energy

Excimer Laser Coronary Atherectomy (ELCA) Spectranetics CVX -300, Spectranetics, Colorado Springs, CO) Wavelength 308 nm Pulse duration 125-200 nS Fluence 30-80 mJ/mm2 Repetition Rate 25-80* Hz Catheter-diameter 0.9 - 2.5 mm 6 FR- compatible Approved by FDA for coronary 1992 for: 1. Dubulking of SVG 5. Total occlusions crossable by guide wire 2. Ostial lesion 6. Moderately calcified lesion 3. Eccentric lesions 7. Balloon refractory lesions 4. Long lesions 20mm 8. In stent restenosis * Acute myocardial infarction

Guiding support Confirm distal bed Saline flush 60/40----60/80----80/80

Washington Hospital Center(2000-2005)

Washington Hospital Center(2005-2011)

Calcified lesion and chronic total occlusion Baseline characteristics Calcified lesion N=25 Chronic total occlusion N=32 Age 71.2±13.2 62.1±11.5 Male 14(56%) 23(71.9%) Hypertension 22(88%) 29(90.6%) Diabetes 9(36%) 15(46.9%) Hyperlipidemia 23(92%) 31(96.9%) Peripheral vascular disease 2(8%) 9(28.1%) Renal failure 15(60%) 18(56.3%) Prior PCI 10(40%) 9(31.0%) Prior CABG 7(28%) 5(15.6%) Ejection fraction 54±11% 45±17%

Chronic total occlusion Procedural data Calcified lesion N=25 Chronic total occlusion N=32 Procedure length (min) 94.4±29.4 106.1±36.4 Contrast (ml) 226.9±115.4 206.9±78.5 Left main LAD CX RCA 1(4%) 5(20%) 4(16%) 15(60%) 5(15.6%) 6(18.7%) 21(65.6%) Stent DES Diameter Length 21(84%) 12(48%) 2.9±0.3 19.1±4.6 26(81.2%) 23(71.8%) 2.8±0.3 24.8±6.9 Laser 0.9mm 1.4mm 1.7mm 2.0mm 23(92%) 27(84.3%) 3(9.3) 1(3.1%) Laser success 20(80%) 30(93.7%) Angiographic success 29(90.1%) Balloon non crossable lesions 14(56%) Concomitant Rota ablation Before After 2(6.2%) IABP 4(16.6%)

Calcified lesion and chronic total occlusion In hospital complication Calcified lesion N=25 Chronic total occlusion N=32 Dissection 3(9.3%) Perforation 1(4%) 1(3.1%) No reflow 2 (8%) Thrombus formation Death Q wave MI Max CKMB (ng/ml) 12.2±22.3 9.8±18.2 Troponin (ng/ml) 11.8±41.0 4.7±11.3 TLR/TVR CABG Stent thrombosis Renal failure 1(4.2%) In hospital dialysis TIA/CVA Vascular complication Major bleeding 2(6.2%)

CASE I- Balloon refractory lesion Clinical history 73 female, diabetes Insulin treatment She has developed progressive S.O.B and chest pain Nuclear stress test –Inferior ischemia

CASE I- Balloon refractory lesion

CASE I- Balloon refractory lesion

CASE I- Balloon refractory lesion Guide – 7F HS Guide wire – Fielder XT Balloon 1.5/8mm APEX did not cross FineCross did not cross (exchange for ROTA wire) ?

CASE I- Balloon refractory lesion 0.9mm OTW Repetition rate of 40Hz and a fluence of 60 mJ/mm2 and then increased to a repetition rate of 80Hz with a fluence of 80 mJ/mm2

CASE I- Balloon refractory lesion Rotablator wire was passed through the OTW laser catheter 1.5mm Rota burr

CASE I- Balloon refractory lesion Balloon 3/12mm Voyager Stent- Xience 3/15mm

CASE II- Chronic total occlusion Clinical History 57 years old male Presented with chest pain He underwent a stress test that was positive –inferior wall PMH: Hyperlpidemia Hypertension

CASE II- Chronic total occlusion Guiding catheter 7F 3DRight

CASE II- Chronic total occlusion CTO 2.1f 135cm Tornus Guide wire.014in MiracleBros 6

CASE II- Chronic total occlusion Guide wire.014in Confianza Balloon 1.5mm 15mm Apex did not cross An Excimer Laser .9mm Did mot cross

CASE II- Chronic total occlusion An anchoring balloon and Excimer Laser .9mm Drug Eluting Stent 2.5mm 30mm Cypher

Summary Laser is a very useful tool in complex coronary intervention including calcified, CTO, SVG, AMI and unexpanded stent Laser is safe and effective for balloon refractory lesions Laser is safe and effective for total occlusions crossable by guide wire

Summary Laser can also be used as an adjunct to facilitate rotational atherectomy calcified lesion – rotational atherectomy better but: -Rotational atherectomy hard to manipulate the guide wire -Can not protect side branch -Can not in AMI -In stent there is risk distal embolization of microparticles